1.
Del Med J
; 77(5): 181-7, 2005 May.
Artículo
en Inglés
| MEDLINE
| ID: mdl-15957261
RESUMEN
Intravenous bisphosphonates have come into increasing use to protect cancer patients from adverse boney events. The prevalence of use, demographics of a treatment population, and occurrence of a particular side effect are explored in this article.